Поисковый запрос: (<.>S=ОТВЕТ НА ЛЕЧЕНИЕ<.>) |
Общее количество найденных документов : 70
Показаны документы с 1 по 20
|
|
1.
| Serum hepatitis C virus RNA levels in chronic hepatitis C - importance for outcome of interferon alfa-2b treatment // Scand. J. Infec. Diseases, 1994. Vol. 26, N 3.-С.263- 270
|
2.
| Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM) // Brit. J. Haematol., 1996. Vol. 92, N 2.-С.420-422
|
3.
| Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM) // Brit. J. Haematol., 1996. Vol. 92, N 2.-С.420-422
|
4.
| Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM) // Brit. J. Haematol., 1996. Vol. 92, N 2.-С.420-422
|
5.
| Wennerberg Predicting response to therapy of squamous cell carcinoma of the head and neck (Review) // Anticancer Res., 1996. Vol. 16, N 4.-С.2389-2396
|
6.
| Prognostic and predictive relevance of c--erbB-2 and ras expression in node positive and negative breast cancer // Anticancer Res., 1994. Vol. 14, N 3b.-С.1441-1450
|
7.
| Prognostic and predictive relevance of c--erbB-2 and ras expression in node positive and negative breast cancer // Anticancer Res., 1994. Vol. 14, N 3b.-С.1441-1450
|
8.
| High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis // Blood, 1996. Vol. 87, N 3.-С.1155-1161
|
9.
| High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis // Blood, 1996. Vol. 87, N 3.-С.1155-1161
|
10.
| Prognostic and predictive relevance of c--erbB-2 and ras expression in node positive and negative breast cancer // Anticancer Res., 1994. Vol. 14, N 3b.-С.1441-1450
|
11.
| High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis // Blood, 1996. Vol. 87, N 3.-С.1155-1161
|
12.
| FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35
|
13.
| Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5
|
14.
| FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35
|
15.
| FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35
|
16.
| Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5
|
17.
| FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35
|
18.
| Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5
|
19.
| Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment // Nature Genet., 1999. Vol. 22, N 2.-С.168-170
|
20.
| van Dalen A. TPS monitoring in metastatic breast cancer // Int. J. Biol. Markers, 1999. Vol. 14, N 1.-С.45-48
|
&uf('+1W2226#',v2226), ?>
|
|